|
|
|
|
 |
|
|
|
Frequently Asked Questions |
|
|
|
|
|
|
|
|
What database programs are available?
|
|
The European Deployment Analyzer database, introduced in 2007, contains information about
25 leading pharmaceutical companies’ sales forces throughout the continent.
The US Deployment Analyzer, introduced in 2008, provides information regarding nearly 60
leading pharmaceutical companies’ sales forces.
The Japan Deployment Analyzer, introduced in 2009, contains information about 25 leading
pharmaceutical companies’ sales forces. |
|
|
|
What countries are represented in the database? |
|
Many worldwide including Austria, Belgium, France, Germany, Italy, Japan, The Netherlands,
Spain, Sweden, Switzerland, the United Kingdom, and the United States.
|
|
|
|
What data is available in the database?
|
PharmaForce’s facile, Web-based database enables users to generate custom reports based
upon any combination of the following variables: country, company, brand,
therapeutic area, and historical timeline (available as an option at a minor
additional cost). The total number of company sales representatives deployed by
sales groups including primary care and specialty/hospital. The number of sales
representatives by therapeutic area. The number of sales representatives (FTEs)
supporting individual brands. Product priorities by sales group, sales force (US
only), and therapeutic area. Data available in the US and Japan Deployment
Analyzers also includes total number of district managers, regional managers and
other sales management by group/division as defined by the target company; sales
group organizational structures; average salaries and bonuses for each sales
force (US) and sales group (Japan); call reach and frequency analysis (US only).
|
|
|
|
What is the research methodology for information gathering in the database?
|
The research for the database relies primarily on unstructured interviews with key sources
at the target companies, including sales representatives, district managers,
product managers, human resource personnel, sales and marketing managers, and
other key employees. PharmaForce’s global database of pharmaceutical industry
contacts approaches 35,000.
|
|
|
How frequently is data updated?
|
Markets worldwide are continuously monitored. The database is updated when solid
information is obtained and verified throughout the year. Our analysts check for
updates for each company at least once per quarter.
|
|
|
Who can access the database?
|
Any employee of your company globally may access the Deployment Analyzer 24/7. It is
accessible from any computer in the world with Internet access. There is no
separate license necessary and it can handle an unlimited number of users.
|
|
|
Does the DA provide historical data?
|
The Deployment Analyzer does provide historical data capabilities as of September 2009.
That information is available as an option at a modest additional fee. European
historical data is available for 2007 through 2010 Japanese historical data is
available for 2009 through 2010 U.S. historical data is available for 2008
through 2010Any employee of your company globally may access the Deployment Analyzer 24/7. It is
accessible from any computer in the world with Internet access. There is no
separate license necessary and it can handle an unlimited number of users.
|
|
|
Which therapeutic areas are covered in the Deployment Analyzer?
|
The following are covered: anti-infectives (includes antibiotics, anti-fungals, and
anti-virals); cardiovascular; CNS, pain and anesthesia; dermatology;
endocrinology and metabolic disorders; gastrointestinal; gynecology/women’s
health; nephrology and transplantation; ophthalmology; respiratory and allergy;
rheumatology, bone and inflammation; urology; vaccines; and others on request.
|
|
|
What is the methodology for determining product FTEs and product promotional
priority?
|
Research analysts gather information from the target company. In some cases, this
information is readily available. In other instances, information is derived
through company source data (e.g., product bonus payout percent and/or product
promotional priority).
|
|
|
What does the abbreviation FTE stand for?
|
FTE = Full-Time Equivalent.
|
|
|
|
What does the abbreviation HCP stand for?
|
HCP = Healthcare Professionals. |
|
|
What does the abbreviation PC stand for?
|
PC = Primary Care. All sales forces that primarily promote brands to primary care
healthcare providers (HCPs) are included under the Primary Care (PC)
classification. This includes sales forces that call on specialty HCPs – as long
as the majority of calls are targeted at primary care HCPs. For example: PC-1767
means promotion through 1,767 primary care FTEs (Full-time equivalents/sales
representatives.)
|
|
|
What does the abbreviation H/Sp stand for?
|
H/Sp = Hospital/Specialty Care. All sales forces that primarily promote brands to
hospital-based or specialty HCPs are included under the Hospital/Specialty Care
classification. This includes sales forces that call on hospital-based and
specialty as well as primary care HCPs as long as the majority of calls are
targeted at hospital-based or specialty HCPs. For example, H/Sp means promotion
through 204 hospital/specialty care FTEs (Full-time Equivalents/Sales
representatives).
|
|
|
|
What does the number "Reach: # of HCP's" represent?
|
The number of Healthcare Professionals on each sales representative call target list.
|
|
|
|
What does the ratio "Reach: % PC versus H/Sp" represent?
|
The ratio shows number of Primary Care HCPs versus number of Hospital/Specialty HCPs each sales
representative calls on.
|
|
|
|
What does the number "Frequency: Calls per Month" represent?
|
The total number of calls per month that each sales representative makes (based on 20 working days per
month).
|
|
|
|
What do the numbers "Frequency: Tier1 - Tier5" represent?
|
The number of times per month that each sales representative calls on each HCP in each tier.
|
|